Gilead Sciences Inc. (GILD) News Headlines

▮ More

Date

Headline

12/16/2019 8:24:22 AM Gilead: Phase 2 ATLAS Data Shows Consistent Improvements In Liver Histology

12/16/2019 8:06:19 AM Gilead Sciences Announces Topline Results From The 48-week, Phase 2 ATLAS Study

12/14/2019 5:17:30 AM Bristol-Myers Wins $752 Mln In US Patent Case Against Gilead Sciences

12/11/2019 9:39:53 PM GILD's KTE-X19 To Face FDA, NTEC Drops As NVS Walks Away, KZIA On Watch

12/11/2019 8:33:58 AM Kite And Kiniksa Enter Clinical Collaboration To Conduct Phase 2, Multicenter Study Of Mavrilimumab

12/10/2019 1:51:30 AM APTO On The Move, PLX To Effect Reverse Split, SCYX Plunges

11/21/2019 8:33:53 AM Charles Calderaro To Join Kite As Global Head Of Technical Operations

11/8/2019 8:08:24 AM US Files Complaint Against Gilead Sciences For Patent Infringement

11/8/2019 8:05:19 AM Gilead Sciences Announces New Data From Nonalcoholic Steatohepatitis Research And Development Program

11/8/2019 8:04:30 AM Gilead Announces New Data From Viral Hepatitis Research Program

10/28/2019 8:03:13 AM Gilead And Glympse Bio Announce Strategic Collaboration In Nonalcoholic Steatohepatitis Clinical Development

10/24/2019 4:32:34 PM Gilead Sciences Inc. Q3 adjusted earnings Beat Estimates

10/24/2019 4:09:52 PM Gilead Sciences Inc. (GILD) Declares Quarterly Dividend of $ 0.63 , Record Date 12/13/2019

10/24/2019 4:08:25 PM Gilead Sciences Q3 Loss Per Share $0.92 Vs EPS $1.60 Last Year

10/15/2019 8:51:54 AM Gilead Sciences Names Andrew Dickinson CFO - Quick Facts

10/15/2019 8:41:31 AM Gilead Sciences Names Andrew Dickinson CFO

10/11/2019 5:54:17 AM MITO Empowered, FPRX Cuts Another 70 Jobs, Second Death In Legionnaires Outbreak

10/8/2019 2:35:19 AM Gilead Announces NDA Submission For Filgotinib In Japan - Quick Facts

10/8/2019 2:29:27 AM Gilead Sciences Submits NDA For Filgotinib For Rheumatoid Arthritis In Japan

10/7/2019 8:34:24 AM Gilead Sciences Appoints Merdad Parsey As Chief Medical Officer